Companies: 10,795·Total market cap: $144.5T
Legend Biotech Corporation

Legend Biotech Corporation

LEGNNASDAQHealthcare● Active
$32.62
$-1.58(-4.62%)
Market Cap$6.0B
P/E Ratio
52W High$45.297
52W Low$16.24
Overview

Legend Biotech Corporation (LEGN) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · LEGN · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-1.36legn eps ttm · legn earnings per shareEarnings history
PE Ratio (TTM)legn pe ratio ttm · legn price to earningsPE Ratio deep dive
Revenue (TTM)$1.1Blegn revenue ttm · legn annual revenueFull revenue history
Dividend YieldNo Dividenddoes legn pay dividends · legn dividend yieldDividend history
Shares Outstanding184.3Mlegn shares outstanding · legn floatShares outstanding history
Next EarningsAug 10, 2026Est.legn earnings date · legn next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$1.03B▲ +64.04% YoY
202320242025
legend biotech corporation revenue · legn revenue 2025
FY 2025Net Income-$296.8M▼ 67.66% YoY
202320242025
legend biotech corporation net income · legn profit 2025
FY 2025EPS$-1.60▼ 64.95% YoY
202320242025
legn eps · legend biotech corporation earnings per share 2025
TTM:Revenue: $1.14BNet Income: -$250.2MEPS: $-1.36View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy19 analystsis legn a buy · legn analyst rating
Strong Buy
0
Buy
16
Hold
3
Sell
0
Strong Sell
0
12-Month Price Target
$24.00Low
$32.62Current
$59.78Avg Target83.26% upside
$75.00High
legn price target · legn 12 month forecast

Total: 19 · Buy rate: 84.2%

The LEGN analyst consensus is Buy, based on ratings from 19 Wall Street analysts over the past 3 months. The average 12-month price target is $59.78, representing +83.26% upside from the current price of $32.62.

Stock Performance

Full History
1D-4.62%
1W-6.75%
1M+16.00%
3M+71.96%
YTD+50.05%
1Y-6.21%
5Y-16.14%

About Legend Biotech Corporation

CEOYing Huang
IPO DateJun 5, 2020
Employees2,600
CountryUS

Legend Biotech Corporation a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in…

what is legend biotech corporation · legn stock overview · legend biotech corporation company profile · who is legend biotech corporation ceo · legn NASDAQ · legend biotech corporation headquarters · legend biotech corporation business segments

About Stock Overview & Key Data

Legend Biotech Corporation (LEGN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 5, 2020. As of the latest trading session, LEGN stock price is $32.62, with a market capitalization of $6.0B. The stock has returned -6.21% over the past 12 months and +50.05% year-to-date.

According to 19 Wall Street analysts, the consensus rating for Legend Biotech Corporation stock is Buy, with an average 12-month price target of $59.78. In fiscal year 2025, Legend Biotech Corporation reported revenue of $1.0B and net income of -$296.8M. For detailed data — including Legend Biotech Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Legend Biotech Corporation (LEGN) stock price is $32.62. The stock is traded on NASDAQ under the ticker symbol LEGN. The 52-week range is $16.24 – $45.30.

LEGN stock priceLEGN quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice